The study suggests that the price of patented medicine in Thailand should be controlled based on equity pricing and outcome pricing. Equity pricing can be estimated from the international reference price and outcome pricing can be evaluated from therapeutic referencing or the pharmacoeconomic price. Moreover, in a case study of 7 medicines granted

Abstract Real-world effectiveness studies are important for monitoring performance of COVID-19 vaccination programmes and informing COVID-19 prevention and control policies. We aimed to synthesise methodological approaches used in COVID-19 vaccine effectiveness studies, in order to evaluate which

As COVID-19 spreads worldwide, national (and sub-national) governments and development partners are making use of a rapidly growing body of evidence to develop policies mitigating against this devastating pandemic. Mathematical models and computational simulation models play a unique role to inform

This policy brief provides a summary of a recent review of the definition of rare diseases, high cost and how HTA has been used in the case of rare diseases in seven countries. The countries were purposively selected based on them having established HTA policies and availability of resources in the

The Indian State of Chhattisgarh is drawing up its plans to extend universal health coverage (UHC) to its people. Discussions among public health experts, practitioners, and lawmakers, therefore, turn to planning the road ahead for this state and how it can deliver on its promise. With the state at

On January 28, 2020, PMAC 2020: Accelerating the Progress Towards UHC officially started with side meetings, with one of the very first ones hosted by Health Intervention and Technology Assessment Program (HITAP), titled “Attain & Sustain Health Gains: Incorporating Value-For-Money in the Univer

PMAC 2016 Side Event (SE 026): Making decision makers accountable: better journalism – better chances of getting to Universal Health CoverageThis workshop will bring together journalists, bloggers and editors from around the world to share stories of reporting countries’ journey towards and efforts

Policymakers across the world are regularly required to make crucial decisions about resource allocation and prioritize interventions – medicine A or medicine B, subsidize heart surgery or expand the immunization program. This process is required to be transparent, accountable a

By Chayapat Rachatan and Kanchanok SirisonOn June 28, 2022, the Health Technology and Assessment Program (HITAP), Ministry of Public Health, Thailand, hosted a workshop on “Health incentive mechanisms present and future: UK’s experience of Pay for Performance and Quality Outcomes Framework (QOF)”. I

PMAC 2016 Side Event (SE 013): Introduction to Health Intervention and Technology Assessment: HITA 101“Health Intervention and Technology Assessment (HITA) is recognized as a tool in support of universal health coverage (UHC) to inform policy decision. It becomes an increasingly important part of pr